You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

OMB157

Showing 1 - 25 of 894
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis Trial in Germany (Ofatumumab)

Active, not recruiting
  • Multiple Sclerosis
  • Berlin, Germany
  • +5 more
Jan 13, 2023

Relapsing Multiple Sclerosis Trial in Boston (Ofatumumab, [F-18]PBR06)

Recruiting
  • Relapsing Multiple Sclerosis
  • Boston, Massachusetts
    Partners MS Center, 60 Fenwood Road
Jul 20, 2021

Relapse Remitting Multiple Sclerosis Trial in United States (Ofatumumab)

Recruiting
  • Relapse Remitting Multiple Sclerosis
  • Chandler, Arizona
  • +16 more
Jan 13, 2023

Relapsing Multiple Sclerosis Trial in Puerto Rico, United States (Ofatumumab)

Recruiting
  • Relapsing Multiple Sclerosis
  • Birmingham, Alabama
  • +16 more
Mar 22, 2022

Multiple Sclerosis Trial in Worldwide (Ofatumumab, First line DMT)

Recruiting
  • Multiple Sclerosis
  • Bayonne, Bayonne Cedex, France
  • +42 more
Jul 25, 2022

Multiple Sclerosis (MS) Trial in Worldwide (Fingolimod, Ofatumumab, Siponimod)

Recruiting
  • Multiple Sclerosis (MS)
  • Little Rock, Arkansas
  • +55 more
Jan 13, 2023

Relapsing Multiple Sclerosis Trial in Worldwide (Ofatumumab)

Recruiting
  • Relapsing Multiple Sclerosis
  • Ofatumumab
  • Cullman, Alabama
  • +165 more
Jan 13, 2023

Relapsing Multiple Sclerosis (RMS) Trial in United States (Ofatumumab, mRNA COVID-19 vaccine, interferon or glatiramer acetate)

Recruiting
  • Relapsing Multiple Sclerosis (RMS)
  • Phoenix, Arizona
  • +3 more
Jul 20, 2022

Superficial Bladder Cancer Trial in United States (ADSTILADRIN)

Active, not recruiting
Has Results
  • Superficial Bladder Cancer
  • ADSTILADRIN
  • Gilbert, Arizona
  • +33 more
Dec 2, 2022

Influenza, Human Trial in United States (NanoFlu (Quad-NIV), Matrix-M Adjuvant, Placebo)

Terminated
Has Results
  • Influenza, Human
  • NanoFlu (Quad-NIV)
  • +5 more
  • Hollywood, Florida
  • +13 more
Nov 3, 2022

Relapsing Multiple Scelrosis Trial in Worldwide (Ofatumumab subcutaneous injection, Teriflunomide-matching capsules,

Completed
Has Results
  • Relapsing Multiple Scelrosis
  • Ofatumumab subcutaneous injection
  • +3 more
  • Birmingham, Alabama
  • +177 more
Oct 21, 2021

Relapsing Multiple Sclerosis Trial in Japan, Russian Federation (Ofatumumab, Matching of ofatumumab)

Completed
Has Results
  • Relapsing Multiple Sclerosis
  • Toon-city, Ehime, Japan
  • +13 more
Apr 27, 2022

Relapsing Multiple Sclerosis Trial in Worldwide (Ofatumumab subcutaneous injection, Teriflunomide-matching capsules,

Completed
Has Results
  • Relapsing Multiple Sclerosis
  • Ofatumumab subcutaneous injection
  • +3 more
  • Phoenix, Arizona
  • +165 more
Sep 3, 2021

Obstructive Sleep Apnea of Adult Trial in South San Francisco (Verily Sleep Apnea (VSA) Program/App)

Completed
Has Results
  • Obstructive Sleep Apnea of Adult
  • Verily Sleep Apnea (VSA) Program/App
  • South San Francisco, California
    Verily Life Sciences LLC
Sep 26, 2022

WOE of Anti-CD20 Therapies

Not yet recruiting
  • Multiple Sclerosis
  • (no location specified)
Oct 31, 2023

Multiple Myeloma Trial in Worldwide (Melphalan flufenamide (Melflufen), Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Whittier, California
  • +19 more
Feb 2, 2022

Postoperative Pain Trial in United States (HTX-011, Saline Placebo, Bupivacaine HCl)

Completed
Has Results
  • Postoperative Pain
  • Mobile, Alabama
  • +14 more
Sep 29, 2021

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in New York (NY-ESO-1 peptide vaccine)

Completed
Has Results
  • Fallopian Tube Cancer
  • +2 more
  • NY-ESO-1 peptide vaccine
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Colitis, Ulcerative, IBD Trial in Worldwide (Placebo IV, Placebo SC, Ustekinumab IV)

Completed
Has Results
  • Colitis, Ulcerative
  • Inflammatory Bowel Diseases
  • Placebo IV
  • +3 more
  • Birmingham, Alabama
  • +253 more
Jan 3, 2023

Multiple Sclerosis Trial in Worldwide (ofatumumab with PRF, ofatumumab with AI)

Completed
Has Results
  • Multiple Sclerosis
  • ofatumumab with PRF
  • ofatumumab with AI
  • Fullerton, California
  • +40 more
Oct 7, 2021

B-cell Chronic Lymphocytic Leukemia Trial in Worldwide (Lenalidomide, Placebo)

Completed
Has Results
  • B-cell Chronic Lymphocytic Leukemia
  • Phoenix, Arizona
  • +240 more
Nov 24, 2021

Tooth Extraction Trial in Bloomington (Clinical Decision Support, Patient education)

Completed
Has Results
  • Tooth Extraction
  • Clinical Decision Support
  • Patient education
  • Bloomington, Minnesota
    HealthPartners Dental Group
Aug 2, 2022

Contraception Trial in United States (Ovaprene)

Completed
Has Results
  • Contraception
  • Ovaprene
  • Sacramento, California
  • +5 more
Jun 7, 2022

Sjögren-Larsson Syndrome Trial in Omaha, Hershey, Fairfax (Active topical NS2 1% dermatologic cream, Vehicle 0.0% NS2

Completed
Has Results
  • Sjögren-Larsson Syndrome
  • Active topical NS2 1% dermatologic cream
  • Vehicle placebo 0.0% NS2 dermatologic cream
  • Omaha, Nebraska
  • +2 more
Nov 16, 2022

Lymphoma, Follicular Trial in Worldwide (Ofatumumab, Bendamustine infusion, Ofatumumab and Bendamustine infusions (Arm A))

Terminated
Has Results
  • Lymphoma, Follicular
  • Tucson, Arizona
  • +139 more
Mar 25, 2020